fulvestrant has been researched along with Obesity in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ameye, L; Awada, A; Azambuja, E; Brandão, M; Caparica, R; De Angelis, C; Desmedt, C; Di Cosimo, S; Eiger, D; Franzoi, MA; Kotecki, N; Lambertini, M; Piccart, M; Ponde, N | 1 |
| Biwer, LA; Carvajal, BV; Jaffe, IZ; Lu, Q; Man, JJ | 1 |
| Lindman, H; Valachis, A; Zewenghiel, L | 1 |
| Bregni, G; de Braud, F; Di Cosimo, S; Festinese, F; Galli, G; Ganzinelli, M; Gevorgyan, A; Lo Vullo, S; Mariani, L; Martinetti, A; Sottotetti, E | 1 |
| Abderrahmani, A; Bosco, D; Cornu, M; Jacovetti, C; Jonas, JC; Laybutt, R; Meugnier, E; Parnaud, G; Peyot, ML; Prentki, M; Regazzi, R; Rome, S; Thorens, B | 1 |
1 trial(s) available for fulvestrant and Obesity
| Article | Year |
|---|---|
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy.
Topics: Adult; Aged; Aged, 80 and over; Aminopyridines; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Benzimidazoles; Body Mass Index; Breast Neoplasms; Confidence Intervals; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Female; Fulvestrant; Humans; Middle Aged; Neutropenia; Obesity; Odds Ratio; Overweight; Placebos; Progression-Free Survival; Thinness; Weight Loss | 2021 |
4 other study(ies) available for fulvestrant and Obesity
| Article | Year |
|---|---|
Mineralocorticoid and Estrogen Receptors in Endothelial Cells Coordinately Regulate Microvascular Function in Obese Female Mice.
Topics: Animals; Endothelium, Vascular; Estrogen Receptor Antagonists; Estrogens; Female; Fulvestrant; Mice; Mice, Knockout; Mice, Obese; Microvessels; Nitric Oxide Synthase Type III; Obesity; Phosphorylation; Receptors, Estrogen; Receptors, Mineralocorticoid; Signal Transduction | 2021 |
Impact of body mass index on the efficacy of endocrine therapy in patients with metastatic breast cancer - A retrospective two-center cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Middle Aged; Neoplasm Metastasis; Obesity; Overweight; Postmenopause; Retrospective Studies; Sweden; Treatment Outcome | 2018 |
Body mass index and clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Body Mass Index; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Obesity; Postmenopause; Receptors, Estrogen; Risk Factors; Treatment Outcome | 2016 |
MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity.
Topics: Adaptation, Physiological; Animals; Cells, Cultured; Cytokines; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Insulin Resistance; Islets of Langerhans; Male; Mice; Mice, Mutant Strains; MicroRNAs; Obesity; Organ Size; Postpartum Period; Pregnancy; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Glucagon; Signal Transduction | 2012 |